Syndax Pharmaceuticals Inc（SNDX）内部人交易：高管与董事近期交易
过去 18 个月，共有 9 位内部人为 Syndax Pharmaceuticals Inc（SNDX）报告了 41 笔 Form 4 交易（最近一笔 2026-07-09）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-09 | Metzger Michael A | Chief Executive Officer | 买入 | 32,375 | $206,552 |
| 2026-07-09 | Metzger Michael A | Chief Executive Officer | 卖出 | 32,375 | $784,776 |
| 2026-06-12 | Botwood Nicholas A.J. | Head of R&D, CMO | 买入 | 22,515 | $311,157 |
| 2026-06-12 | Botwood Nicholas A.J. | Head of R&D, CMO | 卖出 | 34,280 | $617,040 |
| 2026-06-12 | Botwood Nicholas A.J. | Head of R&D, CMO | 买入 | 31,235 | $431,668 |
| 2026-06-12 | Botwood Nicholas A.J. | Head of R&D, CMO | 卖出 | 31,235 | $566,603 |
| 2026-06-02 | Metzger Michael A | Chief Executive Officer | 卖出 | 6,847 | $130,025 |
| 2026-06-02 | Goldan Keith A. | Chief Financial Officer | 卖出 | 1,177 | $22,351 |
| 2026-02-10 | Metzger Michael A | Chief Executive Officer | 卖出 | 17,159 | $360,854 |
| 2026-02-10 | Goldan Keith A. | Chief Financial Officer | 卖出 | 3,410 | $71,712 |
| 2026-02-06 | Metzger Michael A | Chief Executive Officer | 卖出 | 7,412 | $152,835 |
| 2026-02-06 | Metzger Michael A | Chief Executive Officer | 买入 | 144,600 | $0 |
| 2026-02-06 | Metzger Michael A | Chief Executive Officer | 买入 | 73,000 | $0 |
| 2026-02-06 | Huber Martin H. Jr. | 董事 | 买入 | 24,000 | $0 |
| 2026-02-06 | Goldan Keith A. | Chief Financial Officer | 买入 | 1,219 | $10,337 |
| 2026-02-06 | Goldan Keith A. | Chief Financial Officer | 买入 | 21,500 | $0 |
| 2026-02-06 | Goldan Keith A. | Chief Financial Officer | 买入 | 30,750 | $0 |
| 2026-02-06 | Goldan Keith A. | Chief Financial Officer | 卖出 | 2,082 | $42,931 |
| 2026-02-06 | Jarrett Jennifer | 董事 | 买入 | 24,000 | $0 |
| 2026-02-06 | Rizo Aleksandra | 董事 | 买入 | 24,000 | $0 |
| 2026-02-06 | Podlesak Dennis | 董事 | 买入 | 48,000 | $0 |
| 2026-02-06 | Botwood Nicholas A.J. | Head of R&D, CMO | 买入 | 24,000 | $0 |
| 2026-02-06 | Botwood Nicholas A.J. | Head of R&D, CMO | 买入 | 36,000 | $0 |
| 2026-02-06 | Legault Pierre | 董事 | 买入 | 24,000 | $0 |
| 2026-02-06 | Katkin Keith | 董事 | 买入 | 24,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-09